(Q44540663)

4 December 2017

Immunologic evaluation of human bladder cancer: in vitro studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1111918

22 August 2022

Immunologic evaluation of human bladder cancer: In vitro studies (English)

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

26 September 2023

main subject

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1111918

22 August 2022

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

26 September 2023

author name string

M. M. Elhilali

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1111918

22 August 2022

S. K. Nayak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1111918

22 August 2022

language of work or name

English

0 references

publication date

1 February 1975

1 reference

full work available at URL

4 December 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%28197502%2935%3A2%3C419%3A%3AAID-CNCR2820350218%3E3.0.CO%3B2-R

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1111918

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

26 September 2023

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

26 September 2023

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

26 September 2023

1 reference

4 December 2017

35

1 reference

4 December 2017

419-431

1 reference

4 December 2017

2

1 reference

Cross-reacting tstas in adeno 7 and 12 tumors demonstrated by51CR-Cytotoxicity and isograft rejection tests

4 December 2017

1

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Immune response to urinary bladder tumours in man

26 September 2023

2

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Cellular and humoral immune responses to human urinary bladder carcinomas

26 September 2023

3

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

26 September 2023

4

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Cellular immunity to nephroblastoma

26 September 2023

6

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Demonstration of cell-bound and humoral immunity against neuroblastoma cells

26 September 2023

7

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Cellular and Humoral immunity to Different Types of Human Neoplasms

26 September 2023

8

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Demonstration of cell-mediated immunity to human neoplasms of various histological types

26 September 2023

9

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the Disease

26 September 2023

11

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.

26 September 2023

12

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Cellular immunity to human urinary bladder carcinoma. II. EEffect of surgery and preoperative irradiation

26 September 2023

13

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?

26 September 2023

14

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

Applications of Iso-Immune Cytolysis Using Radiolabelled Target Cells

26 September 2023

16

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

A microassay for cell-mediated immunity

26 September 2023

17

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING Cr51-LABELLED TARGET CELLS

26 September 2023

18

1 reference

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197502)35:2%3C419::AID-CNCR2820350218%3E3.0.CO;2-R

26 September 2023

Identifiers

10.1002/1097-0142(197502)35:2<419::AID-CNCR2820350218>3.0.CO;2-R

1 reference

4 December 2017

1 reference